FDA approves first fecal microbe therapy ADC评论 December 2, 2022 On November 30, 2022, Ferring Pharmaceuticals announced that its microbiome therapy REBYOTA® (RBX2660) was approved by the FDA, becoming the first approved fecal microbial therapy. Read More »
Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry October 20, 2023
Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research October 8, 2023
An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries September 19, 2023